China Pharma Holdings (CPHI) Beginning Cash Balance (2013 - 2022)

China Pharma Holdings has reported Beginning Cash Balance for 9 years, with the latest figure at -$4026.0 in Q4 2022.

• For the quarter ending Q4 2022, Beginning Cash Balance fell 101.3% year-over-year to -$4026.0; the trailing twelve-month figure through Dec 2022 stood at $223013.0 (down 60.36% YoY), and the FY2022 full-year result was $223013.0, down 60.36% from the prior year.
• Beginning Cash Balance for Q4 2022 stood at -$4026.0, up from -$4317.0 in the prior quarter.
• The five-year high for Beginning Cash Balance was $310783.0 in Q4 2021, with the low at -$4850.0 in Q2 2022.
• Historically, Beginning Cash Balance has averaged $102821.2 across 4 years, with a median of $111691.0 in 2019.
• Annual changes were most pronounced in 2021 — Beginning Cash Balance soared 172.36% — and 2022, when it slumped 28880.0%.
• China Pharma Holdings' Beginning Cash Balance stood at $111691.0 in 2019, then advanced by 2.16% to $114109.0 in 2020, then surged by 172.36% to $310783.0 in 2021, then sank by 101.3% to -$4026.0 in 2022.
• The last three Beginning Cash Balance figures came in at -$4026.0 (Q4 2022), -$4317.0 (Q3 2022), and -$4850.0 (Q2 2022), per Business Quant data.